Morphine Market Size, Trends, Analysis, and Outlook By Dosage Form (Injection, Oral Tablets, Others), By Application (Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant, Others), by Country, Segment, and Companies, 2024-2032
The global Morphine market size is poised to register 8.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Morphine market across By Dosage Form (Injection, Oral Tablets, Others), By Application (Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant, Others)
The morphine market is poised for significant growth owing to its essential role in pain management, palliative care, and anesthesia induction, as well as the increasing demand for opioid analgesics, opioid rotation strategies, and multimodal pain management approaches that address acute and chronic pain conditions while minimizing opioid-related adverse events, substance abuse risks, and regulatory concerns. With advancements in pharmacokinetics, extended-release formulations, and abuse-deterrent technologies, there is a rising opportunity for morphine manufacturers to offer safe, effective, and individualized treatment options that provide analgesic efficacy, opioid-sparing effects, and improved tolerability profiles for patients with cancer pain, postoperative pain, and end-of-life care needs while ensuring appropriate prescribing practices, medication safety, and regulatory compliance. Further, the expanding applications of morphine in pain control, palliative sedation, and hospice care are driving market expansion further.
Morphine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Morphine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Morphine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Morphine industry.
Key market trends defining the global Morphine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Morphine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Morphine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Morphine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Morphine industry
Leading Morphine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Morphine companies.
Morphine Market Study- Strategic Analysis Review
The Morphine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Morphine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Morphine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Morphine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Morphine market segments. Similarly, Strong market demand is encouraging Canadian Morphine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Morphine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Morphine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Morphine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Morphine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Morphine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Morphine in Asia Pacific. In particular, China, India, and South East Asian Morphine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Morphine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Morphine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Morphine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Morphine.
Morphine Market Company Profiles
The global Morphine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Alcaliber S.A, Daiichi Sankyo Company Ltd, Delpharm (Sandoz Canada Inc), Dr. Reddy's Laboratories Ltd, Hikma Pharmaceuticals USA Inc, Mallinckrodt Pharmaceuticals, Pfizer Inc, Sanofi SA, Sun Pharmaceutical Industries Ltd, Verve Health Care Ltd, Viatris Inc.
Recent Morphine Market Developments
The global Morphine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Morphine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Dosage Form
Injection
Oral Tablets
Others
By Application
Pain Management
-Cancer Pain
-Neuropathic Pain
-Osteoarthritis Pain
-Others
Diarrhea Suppressant
Cold and Cough Suppressant
Others
Geographical Segmentation:
AbbVie Inc
Alcaliber S.A
Daiichi Sankyo Company Ltd
Delpharm (Sandoz Canada Inc)
Dr. Reddy's Laboratories Ltd
Hikma Pharmaceuticals USA Inc
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sanofi SA
Sun Pharmaceutical Industries Ltd
Verve Health Care Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
The morphine market is poised for significant growth owing to its essential role in pain management, palliative care, and anesthesia induction, as well as the increasing demand for opioid analgesics, opioid rotation strategies, and multimodal pain management approaches that address acute and chronic pain conditions while minimizing opioid-related adverse events, substance abuse risks, and regulatory concerns. With advancements in pharmacokinetics, extended-release formulations, and abuse-deterrent technologies, there is a rising opportunity for morphine manufacturers to offer safe, effective, and individualized treatment options that provide analgesic efficacy, opioid-sparing effects, and improved tolerability profiles for patients with cancer pain, postoperative pain, and end-of-life care needs while ensuring appropriate prescribing practices, medication safety, and regulatory compliance. Further, the expanding applications of morphine in pain control, palliative sedation, and hospice care are driving market expansion further.
Morphine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Morphine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Morphine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Morphine industry.
Key market trends defining the global Morphine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Morphine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Morphine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Morphine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Morphine industry
Leading Morphine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Morphine companies.
Morphine Market Study- Strategic Analysis Review
The Morphine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Morphine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Morphine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Morphine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Morphine market segments. Similarly, Strong market demand is encouraging Canadian Morphine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Morphine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Morphine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Morphine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Morphine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Morphine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Morphine in Asia Pacific. In particular, China, India, and South East Asian Morphine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Morphine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Morphine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Morphine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Morphine.
Morphine Market Company Profiles
The global Morphine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Alcaliber S.A, Daiichi Sankyo Company Ltd, Delpharm (Sandoz Canada Inc), Dr. Reddy's Laboratories Ltd, Hikma Pharmaceuticals USA Inc, Mallinckrodt Pharmaceuticals, Pfizer Inc, Sanofi SA, Sun Pharmaceutical Industries Ltd, Verve Health Care Ltd, Viatris Inc.
Recent Morphine Market Developments
The global Morphine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Morphine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Dosage Form
Injection
Oral Tablets
Others
By Application
Pain Management
-Cancer Pain
-Neuropathic Pain
-Osteoarthritis Pain
-Others
Diarrhea Suppressant
Cold and Cough Suppressant
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Alcaliber S.A
Daiichi Sankyo Company Ltd
Delpharm (Sandoz Canada Inc)
Dr. Reddy's Laboratories Ltd
Hikma Pharmaceuticals USA Inc
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sanofi SA
Sun Pharmaceutical Industries Ltd
Verve Health Care Ltd
Viatris Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Morphine Market Overview and Key Findings, 2024
1.2 Morphine Market Size and Growth Outlook, 2021- 2030
1.3 Morphine Market Growth Opportunities to 2030
1.4 Key Morphine Market Trends and Challenges
1.4.1 Morphine Market Drivers and Trends
1.4.2 Morphine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Morphine Companies
2. MORPHINE MARKET SIZE OUTLOOK TO 2030
2.1 Morphine Market Size Outlook, USD Million, 2021- 2030
2.2 Morphine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. MORPHINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. MORPHINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Dosage Form
Injection
Oral Tablets
Others
By Application
Pain Management
-Cancer Pain
-Neuropathic Pain
-Osteoarthritis Pain
-Others
Diarrhea Suppressant
Cold and Cough Suppressant
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Morphine Market, 2025
5.2 Asia Pacific Morphine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Morphine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Morphine Market, 2025
5.5 Europe Morphine Market Size Outlook by Type, 2021- 2030
5.6 Europe Morphine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Morphine Market, 2025
5.8 North America Morphine Market Size Outlook by Type, 2021- 2030
5.9 North America Morphine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Morphine Market, 2025
5.11 South America Pacific Morphine Market Size Outlook by Type, 2021- 2030
5.12 South America Morphine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Morphine Market, 2025
5.14 Middle East Africa Morphine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Morphine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Morphine Market Size Outlook and Revenue Growth Forecasts
6.2 US Morphine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Morphine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Morphine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Morphine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Morphine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Morphine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Morphine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Morphine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Morphine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Morphine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Morphine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Morphine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Morphine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Morphine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Morphine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Morphine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Morphine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Morphine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Morphine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Morphine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Morphine Industry Drivers and Opportunities
7. MORPHINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. MORPHINE COMPANY PROFILES
8.1 Profiles of Leading Morphine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Alcaliber S.A
Daiichi Sankyo Company Ltd
Delpharm (Sandoz Canada Inc)
Dr. Reddy's Laboratories Ltd
Hikma Pharmaceuticals USA Inc
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sanofi SA
Sun Pharmaceutical Industries Ltd
Verve Health Care Ltd
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Morphine Market Overview and Key Findings, 2024
1.2 Morphine Market Size and Growth Outlook, 2021- 2030
1.3 Morphine Market Growth Opportunities to 2030
1.4 Key Morphine Market Trends and Challenges
1.4.1 Morphine Market Drivers and Trends
1.4.2 Morphine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Morphine Companies
2. MORPHINE MARKET SIZE OUTLOOK TO 2030
2.1 Morphine Market Size Outlook, USD Million, 2021- 2030
2.2 Morphine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. MORPHINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. MORPHINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Dosage Form
Injection
Oral Tablets
Others
By Application
Pain Management
-Cancer Pain
-Neuropathic Pain
-Osteoarthritis Pain
-Others
Diarrhea Suppressant
Cold and Cough Suppressant
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Morphine Market, 2025
5.2 Asia Pacific Morphine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Morphine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Morphine Market, 2025
5.5 Europe Morphine Market Size Outlook by Type, 2021- 2030
5.6 Europe Morphine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Morphine Market, 2025
5.8 North America Morphine Market Size Outlook by Type, 2021- 2030
5.9 North America Morphine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Morphine Market, 2025
5.11 South America Pacific Morphine Market Size Outlook by Type, 2021- 2030
5.12 South America Morphine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Morphine Market, 2025
5.14 Middle East Africa Morphine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Morphine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Morphine Market Size Outlook and Revenue Growth Forecasts
6.2 US Morphine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Morphine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Morphine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Morphine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Morphine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Morphine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Morphine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Morphine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Morphine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Morphine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Morphine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Morphine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Morphine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Morphine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Morphine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Morphine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Morphine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Morphine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Morphine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Morphine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Morphine Industry Drivers and Opportunities
7. MORPHINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. MORPHINE COMPANY PROFILES
8.1 Profiles of Leading Morphine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Alcaliber S.A
Daiichi Sankyo Company Ltd
Delpharm (Sandoz Canada Inc)
Dr. Reddy's Laboratories Ltd
Hikma Pharmaceuticals USA Inc
Mallinckrodt Pharmaceuticals
Pfizer Inc
Sanofi SA
Sun Pharmaceutical Industries Ltd
Verve Health Care Ltd
Viatris Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
